{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:32:26Z","timestamp":1792096346258,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,4,6]],"date-time":"2010-04-06T00:00:00Z","timestamp":1270512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s11914-010-0010-7","type":"journal-article","created":{"date-parts":[[2010,4,5]],"date-time":"2010-04-05T00:16:28Z","timestamp":1270426588000},"page":"77-83","source":"Crossref","is-referenced-by-count":17,"title":["Role of Cartilage-Associated Protein in Skeletal Development"],"prefix":"10.1007","volume":"8","author":[{"given":"Roy","family":"Morello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,6]]},"reference":[{"key":"10_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/9780470623992.ch6","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"P Gehron Robey","year":"2008","unstructured":"Gehron Robey P, Boskey A: The composition of bone. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Edited by Rosen CJ. Washington, DC: American Society for Bone and Mineral Research; 2008:32\u201338."},{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tig.2003.11.004","volume":"20","author":"J Myllyharju","year":"2004","unstructured":"Myllyharju J, Kivirikko KI: Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 2004, 20:33\u201343.","journal-title":"Trends Genet"},{"issue":"Pt 12","key":"10_CR3","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1242\/jcs.110.12.1351","volume":"110","author":"P Castagnola","year":"1997","unstructured":"Castagnola P, Gennari M, Morello R, et al.: Cartilage associated protein (CASP) is a novel developmentally regulated chick embryo protein. J Cell Sci 1997, 110(Pt 12):1351\u20131359.","journal-title":"J Cell Sci"},{"key":"10_CR4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0945-053X(99)00002-5","volume":"18","author":"R Morello","year":"1999","unstructured":"Morello R, Tonachini L, Monticone M, et al.: cDNA cloning, characterization and chromosome mapping of Crtap encoding the mouse cartilage associated protein. Matrix Biol 1999, 18:319\u2013324.","journal-title":"Matrix Biol"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello R, Bertin TK, Chen Y, et al.: CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 2006, 127:291\u2013304.","journal-title":"Cell"},{"key":"10_CR6","unstructured":"Morello R, Baldridge D, Lennington J, et al.: Comparative Phenotypic and Biochemical Analyses of Crtap \u2212\/\u2212 Mice and Patients with Recessive Osteogenesis Imperfecta. [abstract FR0141]. Presented at the ASBMR 31st Annual Meeting. Denver, CO; September 11\u201315, 2009."},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"23615","DOI":"10.1074\/jbc.M312807200","volume":"279","author":"JA Vranka","year":"2004","unstructured":"Vranka JA, Sakai LY, Bachinger HP: Prolyl 3-hydroxylase 1: enzyme characterization and identification of a novel family of enzymes. J Biol Chem 2004, 279:23615\u201323621.","journal-title":"J Biol Chem"},{"key":"10_CR8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbrc.2004.03.060","volume":"317","author":"S Jarnum","year":"2004","unstructured":"Jarnum S, Kjellman C, Darabi A, et al.: LEPREL1, a novel ER and Golgi resident member of the Leprecan family. Biochem Biophys Res Commun 2004, 317:342\u2013351.","journal-title":"Biochem Biophys Res Commun"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH: Osteogenesis imperfecta. Lancet 2004, 363:1377\u20131385.","journal-title":"Lancet"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","volume":"31","author":"LM Ward","year":"2002","unstructured":"Ward LM, Rauch F, Travers R, et al.: Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 2002, 31:12\u201318.","journal-title":"Bone"},{"key":"10_CR11","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","volume":"15","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Rauch F, Plotkin H, et al.: Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 2000, 15:1650\u20131658.","journal-title":"J Bone Miner Res"},{"key":"10_CR12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","volume":"17","author":"FH Glorieux","year":"2002","unstructured":"Glorieux FH, Ward LM, Rauch F, et al.: Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 2002, 17:30\u201338.","journal-title":"J Bone Miner Res"},{"key":"10_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S8756-3282(02)00808-6","volume":"31","author":"M Labuda","year":"2002","unstructured":"Labuda M, Morissette J, Ward LM, et al.: Osteogenesis imperfecta type VII maps to the short arm of chromosome 3. Bone 2002, 31:19\u201325.","journal-title":"Bone"},{"key":"10_CR14","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1056\/NEJMoa063804","volume":"355","author":"AM Barnes","year":"2006","unstructured":"Barnes AM, Chang W, Morello R, et al.: Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 2006, 355:2757\u20132764.","journal-title":"N Engl J Med"},{"key":"10_CR15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/humu.20799","volume":"29","author":"D Baldridge","year":"2008","unstructured":"\u2022 Baldridge, D., Schwarze U, Morello R, et al.: CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat 2008, 29:1435\u20131442. This article provides clinical and molecular information of patients with recessive OI and expands the phenotype of the disorder.","journal-title":"Hum Mutat"},{"key":"10_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/hmg\/ddn374","volume":"18","author":"DL Bodian","year":"2009","unstructured":"Bodian DL, Chan TF, Poon A, et al.: Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships. Hum Mol Genet 2009, 18:463\u2013471.","journal-title":"Hum Mol Genet"},{"key":"10_CR17","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ejhg.2009.75","volume":"17","author":"FS Dijk Van","year":"2009","unstructured":"\u2022 Van Dijk FS, Nesbitt IM, Nikkels PG, et al.: CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis. Eur J Hum Genet 2009, 17:1560\u20131569. This article describes the phenotype of recessive OI due to CRTAP mutations and discusses the diagnostic work-up in such patients.","journal-title":"Eur J Hum Genet"},{"key":"10_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00223-008-9211-9","volume":"84","author":"MS Cheung","year":"2009","unstructured":"Cheung MS, Glorieux FH, Rauch F: Intravenous pamidronate in osteogenesis imperfecta type VII. Calcif Tissue Int 2009, 84:203\u2013209.","journal-title":"Calcif Tissue Int"},{"key":"10_CR19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/humu.20799","volume":"29","author":"D Baldridge","year":"2008","unstructured":"Baldridge D, Schwarze U, Morello R, et al.: CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat 2008, 29:1435\u20131442.","journal-title":"Hum Mutat"},{"issue":"5 Pt 1","key":"10_CR20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","volume":"111","author":"L Zeitlin","year":"2003","unstructured":"Zeitlin L, Rauch F, Plotkin H, Glorieux FH: Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 2003, 111(5 Pt 1):1030\u20131036.","journal-title":"Pediatrics"},{"key":"10_CR21","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/ajmg.a.32508","volume":"146A","author":"AA Obafemi","year":"2008","unstructured":"Obafemi AA, Bulas DI, Troendle J, Marini JC: Popcorn calcification in osteogenesis imperfecta: incidence, progression, and molecular correlation. Am J Med Genet A 2008, 146A:2725\u20132732.","journal-title":"Am J Med Genet A"},{"key":"10_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bone.2004.03.008","volume":"35","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Mier RJ, Glorieux FH: Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta. Bone 2004, 35:231\u2013234.","journal-title":"Bone"},{"key":"10_CR23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1968","volume":"39","author":"WA Cabral","year":"2007","unstructured":"\u2022\u2022 Cabral WA, Chang W, Barnes AM, et al.: Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta. Nat Genet 2007, 39:359\u2013365. This is the first article describing LEPRE1 mutations in recessive OI patients.","journal-title":"Nat Genet"},{"key":"10_CR24","doi-asserted-by":"crossref","first-page":"17641","DOI":"10.1074\/jbc.M109.007070","volume":"284","author":"Y Ishikawa","year":"2009","unstructured":"\u2022\u2022 Ishikawa Y, Wirz J, Vranka JA, et al.: Biochemical characterization of the prolyl 3-hydroxylase 1.cartilage-associated protein.cyclophilin B complex. J Biol Chem 2009, 284:17641\u201317647. This study demonstrates that the prolyl 3-hydroxylation complex, formed by Crtap\/P3h1\/CypB, also has collagen chaperone activity.","journal-title":"J Biol Chem"},{"key":"10_CR25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ajhg.2009.09.001","volume":"85","author":"FFS Glorieux","year":"2009","unstructured":"\u2022\u2022 Glorieux FFS, Nesbitt IM, Zwikstra EH, et al.: PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 2009, 85:521\u2013527. This study demonstrates that mutations in the gene encoding the third component of the prolyl 3-hydroxylation complex, CypB, also cause recessive OI.","journal-title":"Am J Hum Genet"},{"key":"10_CR26","unstructured":"\u2022 Alanay Y, Avaygan H, Camacho N, et al.: Mutations in a gene encoding a rough endoplasmic reticulum protein causes autosomal recessive progressive deforming osteogenesis imperfecta. [abstract 212]. Presented at the ASHG 59th Annual Meeting. Honolulu, HI; October 20\u201324, 2009. Identification of FKBP65 mutations, another collagen chaperone molecule, in recessive OI cases negative for mutation in COL1A1, COL1A2, CRTAP, and LEPRE1 demonstrates the importance of collagen chaperone molecules in human disease."},{"key":"10_CR27","doi-asserted-by":"crossref","first-page":"e1000579","DOI":"10.1371\/journal.pgen.1000579","volume":"5","author":"C Drogemuller","year":"2009","unstructured":"\u2022 Drogemuller C, Becker D, Brunner A, et al.: A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta. PLoS Genet 2009, 5:e1000579. This article identifies the first mutations in the gene coding HSP47, a collagen-specific chaperone, in a dog strain affected with recessive OI.","journal-title":"PLoS Genet"},{"key":"10_CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0945-053X(03)00006-4","volume":"22","author":"J Myllyharju","year":"2003","unstructured":"Myllyharju J: Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol 2003, 22:15\u201324.","journal-title":"Matrix Biol"},{"key":"10_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-12-363706-2.50008-8","volume":"6","author":"NA Kefalides","year":"1973","unstructured":"Kefalides NA: Structure and biosynthesis of basement membranes. Int Rev Connect Tissue Res 1973, 6:63\u2013104.","journal-title":"Int Rev Connect Tissue Res"},{"key":"10_CR30","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1021\/ja034015j","volume":"125","author":"CL Jenkins","year":"2003","unstructured":"Jenkins CL, Bretscher LE, Guzei IA, Raines RT: Effect of 3-hydroxyproline residues on collagen stability. J Am Chem Soc 2003, 125:6422\u20136427.","journal-title":"J Am Chem Soc"},{"key":"10_CR31","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1111\/j.1742-4658.2008.06704.x","volume":"275","author":"K Mizuno","year":"2008","unstructured":"Mizuno K, Peyton DH, Hayashi T, et al.: Effect of the -Gly-3(S)-hydroxyprolyl-4(R)-hydroxyprolyl- tripeptide unit on the stability of collagen model peptides. FEBS J 2008, 275:5830\u20135840.","journal-title":"FEBS J"},{"issue":"Pt 4","key":"10_CR32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1242\/jcs.95.4.649","volume":"95","author":"DE Birk","year":"1990","unstructured":"Birk DE, Fitch JM, Babiarz JP, et al.: Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci 1990, 95(Pt 4):649\u2013657.","journal-title":"J Cell Sci"},{"key":"10_CR33","doi-asserted-by":"crossref","first-page":"53331","DOI":"10.1074\/jbc.M409622200","volume":"279","author":"RJ Wenstrup","year":"2004","unstructured":"Wenstrup RJ, Florer, JB, Brunskill EW, et al.: Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem 2004, 279:53331\u201353337.","journal-title":"J Biol Chem"},{"key":"10_CR34","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/hmg\/5.11.1733","volume":"5","author":"RJ Wenstrup","year":"1996","unstructured":"Wenstrup RJ, Langland GT, Willing MC, et al.: A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum Mol Genet 1996, 5:1733\u20131736.","journal-title":"Hum Mol Genet"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-010-0010-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-010-0010-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-010-0010-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T09:57:17Z","timestamp":1635155837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-010-0010-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1007\/s11914-010-0010-7","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,6]]}}}